Direktorat Registrasi ObatValid

REBAMAX

BPOM Number: DKL1328206517A1
Approved: 21 November 2024
Expiry: 14 February 2025
Form: TABLET SALUT SELAPUT; 100 MG

About This Registration

REBAMAX is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL1328206517A1. Its current registration status is Valid, with the licence valid until 14 February 2025. The product is registered to SIMEX PHARMACEUTICAL INDONESIA - INDONESIA. BPOM first approved this registration in February 2020. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 3 BLISTER @ 10 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

SIMEX PHARMACEUTICAL INDONESIA - INDONESIA
KAB. SUKABUMI
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

SIMEX PHARMACEUTICAL INDONESIA - INDONESIA
KAB. SUKABUMI
primary
View profile →

Ingredients (1)

REBAMIPIDE

Market Intelligence

Owner Portfolio: SIMEX PHARMACEUTICAL INDONESIA - INDONESIA holds 115 BPOM registrations
Manufacturer Scale: SIMEX PHARMACEUTICAL INDONESIA - INDONESIA produces 115 registered products
Registration Age: Registered for 6 years, 7 months
Expiry Status: Expired 588 days ago